Scarica l'app Stockscreener
231.59
0.51%
-1.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$232.78
Aprire:
$234
Volume 24 ore:
55.12M
Relative Volume:
1.00
Capitalizzazione di mercato:
$3.44T
Reddito:
$408.63B
Utile/perdita netta:
$99.28B
Rapporto P/E:
35.14
EPS:
6.59
Flusso di cassa netto:
$96.18B
1 W Prestazione:
+0.98%
1M Prestazione:
+10.75%
6M Prestazione:
-5.32%
1 anno Prestazione:
+3.06%
Intervallo 1D:
$229.34
$234.28
Intervallo di 1 settimana:
$224.76
$235.12
Portata 52W:
$169.21
$260.10
Apple Inc Stock (AAPL) Company Profile
Nome
Apple Inc
Settore
Industria
Telefono
(408) 996-1010
Indirizzo
ONE APPLE PARK WAY, CUPERTINO, CA
Confronta AAPL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AAPL
Apple Inc
|
231.59 | 3.45T | 408.63B | 99.28B | 96.18B | 6.59 |
|
SONY
Sony Group Corporation Adr
|
28.74 | 166.24B | 83.81B | 7.93B | 18.33B | 1.2696 |
|
LPL
Lg Display Co Ltd Adr
|
4.44 | 4.35B | 19.69B | -1.47B | -1.21B | -1.481 |
|
SONO
Sonos Inc
|
12.96 | 1.59B | 1.52B | -38.15M | 134.66M | -0.33 |
|
TBCH
Turtle Beach Corp
|
15.61 | 313.34M | 0 | 0 | 0 | 0.00 |
Apple Inc Stock (AAPL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-07 | Reiterato | BofA Securities | Buy |
| 2025-08-01 | Reiterato | Barclays | Underweight |
| 2025-08-01 | Reiterato | BofA Securities | Buy |
| 2025-08-01 | Reiterato | Citigroup | Buy |
| 2025-08-01 | Reiterato | JP Morgan | Overweight |
| 2025-08-01 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-08-01 | Reiterato | Morgan Stanley | Overweight |
| 2025-08-01 | Reiterato | Raymond James | Outperform |
| 2025-08-01 | Reiterato | UBS | Neutral |
| 2025-07-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-06-26 | Reiterato | JP Morgan | Overweight |
| 2025-06-04 | Downgrade | Needham | Buy → Hold |
| 2025-05-02 | Downgrade | Jefferies | Hold → Underperform |
| 2025-05-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-05-02 | Downgrade | Rosenblatt | Buy → Neutral |
| 2025-05-02 | Reiterato | TD Cowen | Buy |
| 2025-04-30 | Reiterato | Barclays | Underweight |
| 2025-04-30 | Reiterato | Loop Capital | Hold |
| 2025-04-29 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-28 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-24 | Reiterato | BofA Securities | Buy |
| 2025-04-22 | Ripresa | China Renaissance | Buy |
| 2025-04-14 | Reiterato | JP Morgan | Overweight |
| 2025-04-14 | Aggiornamento | KeyBanc Capital Markets | Underweight → Sector Weight |
| 2025-04-09 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-04-08 | Reiterato | KeyBanc Capital Markets | Underweight |
| 2025-04-08 | Reiterato | Morgan Stanley | Overweight |
| 2025-03-18 | Reiterato | Evercore ISI | Outperform |
| 2025-01-31 | Reiterato | KeyBanc Capital Markets | Underweight |
| 2025-01-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-01-28 | Reiterato | TD Cowen | Buy |
| 2025-01-24 | Reiterato | BofA Securities | Buy |
| 2025-01-23 | Reiterato | Goldman | Buy |
| 2025-01-21 | Downgrade | Jefferies | Hold → Underperform |
| 2025-01-21 | Downgrade | Loop Capital | Buy → Hold |
| 2025-01-07 | Downgrade | MoffettNathanson | Neutral → Sell |
| 2025-01-03 | Reiterato | Bernstein | Outperform |
| 2024-12-26 | Reiterato | Wedbush | Outperform |
| 2024-12-02 | Reiterato | UBS | Neutral |
| 2024-11-19 | Reiterato | MoffettNathanson | Neutral |
| 2024-11-04 | Reiterato | Loop Capital | Buy |
| 2024-11-01 | Reiterato | Maxim Group | Hold |
| 2024-10-25 | Downgrade | KeyBanc Capital Markets | Sector Weight → Underweight |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-19 | Iniziato | MoffettNathanson | Neutral |
| 2024-08-02 | Reiterato | Maxim Group | Hold |
| 2024-08-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-07-29 | Reiterato | TD Cowen | Buy |
| 2024-07-24 | Reiterato | JP Morgan | Overweight |
| 2024-07-15 | Aggiornamento | Loop Capital | Hold → Buy |
| 2024-07-15 | Reiterato | Morgan Stanley | Overweight |
| 2024-07-11 | Reiterato | BofA Securities | Buy |
| 2024-07-10 | Reiterato | Needham | Buy |
| 2024-07-09 | Reiterato | Piper Sandler | Neutral |
| 2024-06-28 | Reiterato | Oppenheimer | Outperform |
| 2024-06-26 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2024-06-25 | Reiterato | Evercore ISI | Outperform |
| 2024-06-25 | Reiterato | Maxim Group | Hold |
| 2024-06-18 | Reiterato | JP Morgan | Overweight |
| 2024-06-11 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2024-05-03 | Aggiornamento | Itau BBA | Underperform → Market Perform |
| 2024-05-03 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-04-29 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-04-17 | Iniziato | Maxim Group | Hold |
| 2024-04-11 | Reiterato | JP Morgan | Overweight |
| 2024-03-28 | Downgrade | DZ Bank | Buy → Hold |
| 2024-02-02 | Reiterato | Barclays | Underweight |
| 2024-02-02 | Reiterato | Goldman | Buy |
| 2024-02-02 | Reiterato | JP Morgan | Overweight |
| 2024-02-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Reiterato | Piper Sandler | Neutral |
| 2024-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2024-01-18 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-10 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2024-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-03 | Ripresa | DA Davidson | Neutral |
| 2024-01-02 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-12-22 | Reiterato | Needham | Buy |
| 2023-10-31 | Reiterato | Jefferies | Buy |
| 2023-10-16 | Reiterato | Morgan Stanley | Overweight |
| 2023-10-04 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-13 | Reiterato | BofA Securities | Neutral |
| 2023-09-13 | Reiterato | Goldman | Buy |
| 2023-09-13 | Reiterato | Wedbush | Outperform |
| 2023-08-04 | Reiterato | Barclays | Equal Weight |
| 2023-08-04 | Reiterato | Canaccord Genuity | Buy |
| 2023-08-04 | Reiterato | Jefferies | Buy |
| 2023-08-04 | Reiterato | Morgan Stanley | Overweight |
| 2023-08-04 | Reiterato | Oppenheimer | Outperform |
| 2023-08-04 | Reiterato | Raymond James | Outperform |
| 2023-08-04 | Downgrade | Rosenblatt | Buy → Neutral |
| 2023-08-04 | Reiterato | Wedbush | Outperform |
| 2023-08-01 | Reiterato | JP Morgan | Overweight |
| 2023-08-01 | Reiterato | Robert W. Baird | Outperform |
| 2023-08-01 | Reiterato | TD Cowen | Outperform |
| 2023-07-31 | Reiterato | Piper Sandler | Overweight |
| 2023-07-27 | Reiterato | Bernstein | Mkt Perform |
| 2023-07-24 | Reiterato | Deutsche Bank | Buy |
| 2023-07-19 | Reiterato | BofA Securities | Neutral |
| 2023-07-17 | Reiterato | Morgan Stanley | Overweight |
| 2023-07-11 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-06-30 | Iniziato | Citigroup | Buy |
| 2023-06-13 | Downgrade | UBS | Buy → Neutral |
| 2023-06-06 | Downgrade | DA Davidson | Buy → Neutral |
| 2023-05-05 | Reiterato | Atlantic Equities | Overweight |
| 2023-05-05 | Reiterato | BofA Securities | Neutral |
| 2023-05-05 | Reiterato | Canaccord Genuity | Buy |
| 2023-05-05 | Reiterato | DA Davidson | Buy |
| 2023-05-05 | Reiterato | Deutsche Bank | Buy |
| 2023-05-05 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Reiterato | Monness Crespi & Hardt | Buy |
| 2023-05-05 | Reiterato | Morgan Stanley | Overweight |
| 2023-05-05 | Reiterato | Needham | Buy |
| 2023-05-05 | Reiterato | Piper Sandler | Overweight |
| 2023-05-05 | Reiterato | Rosenblatt | Buy |
| 2023-05-01 | Reiterato | BofA Securities | Neutral |
| 2023-04-26 | Reiterato | Barclays | Equal Weight |
| 2023-04-26 | Reiterato | Deutsche Bank | Buy |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-06 | Reiterato | BofA Securities | Neutral |
| 2023-03-06 | Iniziato | Goldman | Buy |
| 2023-03-03 | Reiterato | Morgan Stanley | Overweight |
| 2023-01-27 | Reiterato | BofA Securities | Neutral |
| 2023-01-23 | Reiterato | Deutsche Bank | Buy |
| 2023-01-18 | Reiterato | Canaccord Genuity | Buy |
| 2023-01-03 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2022-12-20 | Reiterato | JP Morgan | Overweight |
| 2022-12-12 | Reiterato | Oppenheimer | Outperform |
| 2022-10-28 | Reiterato | Barclays | Equal Weight |
| 2022-10-28 | Reiterato | Citigroup | Buy |
| 2022-10-28 | Reiterato | Credit Suisse | Outperform |
| 2022-10-28 | Reiterato | DA Davidson | Buy |
| 2022-10-28 | Reiterato | Deutsche Bank | Buy |
| 2022-10-28 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-10-28 | Reiterato | Robert W. Baird | Outperform |
| 2022-10-28 | Reiterato | Wedbush | Outperform |
| 2022-10-17 | Reiterato | Morgan Stanley | Overweight |
| 2022-10-13 | Reiterato | Credit Suisse | Outperform |
| 2022-10-11 | Reiterato | Barclays | Equal Weight |
| 2022-09-29 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2022-06-28 | Reiterato | Evercore ISI | Outperform |
| 2022-05-25 | Reiterato | Loop Capital | Buy |
| 2022-04-19 | Iniziato | Rosenblatt | Neutral |
| 2022-01-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2022-01-28 | Aggiornamento | New Street | Sell → Neutral |
| 2021-12-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-12-13 | Reiterato | JP Morgan | Overweight |
| 2021-12-07 | Reiterato | Morgan Stanley | Overweight |
| 2021-12-06 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-10-29 | Ripresa | Credit Suisse | Neutral |
| 2021-09-15 | Reiterato | Cowen | Outperform |
| 2021-09-01 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2021-08-19 | Reiterato | JP Morgan | Overweight |
| 2021-07-28 | Reiterato | Barclays | Equal Weight |
| 2021-07-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-28 | Reiterato | Deutsche Bank | Buy |
| 2021-07-28 | Reiterato | Loop Capital | Buy |
| 2021-07-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-07-28 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-28 | Reiterato | Oppenheimer | Outperform |
| 2021-07-28 | Reiterato | Piper Sandler | Overweight |
| 2021-07-28 | Reiterato | Wells Fargo | Overweight |
| 2021-07-28 | Reiterato | Wolfe Research | Underperform |
| 2021-07-22 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-20 | Reiterato | UBS | Buy |
| 2021-07-14 | Reiterato | JP Morgan | Overweight |
| 2021-07-06 | Reiterato | JP Morgan | Overweight |
| 2021-06-24 | Reiterato | Morgan Stanley | Overweight |
| 2021-05-28 | Downgrade | New Street | Neutral → Sell |
| 2021-04-29 | Aggiornamento | Goldman | Sell → Neutral |
| 2021-04-06 | Reiterato | Morgan Stanley | Overweight |
| 2021-03-31 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-01-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-28 | Reiterato | Needham | Buy |
| 2021-01-25 | Reiterato | Wedbush | Outperform |
| 2021-01-22 | Reiterato | Cowen | Outperform |
| 2021-01-21 | Reiterato | Morgan Stanley | Overweight |
| 2021-01-05 | Reiterato | Canaccord Genuity | Buy |
| 2020-12-16 | Reiterato | Morgan Stanley | Overweight |
| 2020-12-09 | Reiterato | Wedbush | Outperform |
| 2020-11-30 | Aggiornamento | Loop Capital | Hold → Buy |
| 2020-10-26 | Ripresa | Atlantic Equities | Overweight |
| 2020-09-21 | Reiterato | Citigroup | Buy |
| 2020-09-17 | Reiterato | Jefferies | Buy |
| 2020-09-16 | Reiterato | Needham | Buy |
| 2020-09-14 | Reiterato | Oppenheimer | Outperform |
| 2020-09-01 | Reiterato | Cowen | Outperform |
| 2020-09-01 | Reiterato | JP Morgan | Overweight |
| 2020-08-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-08-26 | Reiterato | Wedbush | Outperform |
| 2020-08-25 | Reiterato | Cowen | Outperform |
| 2020-08-24 | Reiterato | Morgan Stanley | Overweight |
| 2020-08-10 | Reiterato | Wedbush | Outperform |
| 2020-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-31 | Reiterato | Oppenheimer | Outperform |
| 2020-07-31 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-07-31 | Reiterato | UBS | Buy |
| 2020-07-31 | Reiterato | Wedbush | Outperform |
Mostra tutto
Apple Inc Borsa (AAPL) Ultime notizie
Pomerantz Law Firm Announces the Filing of a Class Action Against Apple Inc. and Certain OfficersAAPL - PR Newswire
This Red-Hot Vanguard ETF Just Hit an All-Time High. Here's Why It's Still Worth Buying in August. - The Motley Fool
Three game-changing new Apple CarPlay features expected with iOS 26 update - USA Today
Warren Buffet dumps Apple and Bank of America - Daily Investor
Apple to tap into AI expansion with robots and lifelike Siri - Cybernews
Warren Buffett’s Most Profitable Investment — And the Lessons That Could Make You Rich - Investopedia
Apple's iPhone Production Hike and Pricing Power Signal a Potential Turnaround in 2025 - AInvest
APPLE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Apple Inc.AAPL - Morningstar
Maverick Capital Ltd Increases Stake in Apple Inc - TipRanks
Driehaus Capital Management Reduces Stake in Apple Inc - TipRanks
Berkshire Hathaway Reduces Stake in Apple Inc - TipRanks
Mairs & Power Inc Reduces Stake in Apple Inc - TipRanks
Morgan Stanley Boosts Apple iPhone Production Forecast to 54M Units - WebProNews
Warren Buffett buys battered UnitedHealth, sells more Apple stock - TheStreet
Trump Teases 300% Chip Tariffs--Apple May Get a Pass, Others Could Pay Big - Yahoo Finance
AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Jim Cramer backs Apple, touts relationship with President Trump and long-term growth potential - MacDailyNews
Jim Cramer Defends Apple Inc. (AAPL) Against Elon Musk - MSN
Apple: $94 Billion Record Earnings and the Breakthrough Climate Solutions Fueling Growth - CarbonCredits.com
Warren Buffett's Top 10 Berkshire Bets Span Apple, Coca-Cola, Finance And Oil - Benzinga
Morgan Stanley turns more optimistic on Apple as iPhone outlook improves - TradingView
Life after the Apple App Store - Computerworld
Duan Yongping's Strategic Moves: A Closer Look at Apple Inc. and Other Key Investments - Yahoo Finance
Apple CEO Tim Cook Says the Technology They’re Developing Will Be ‘One of the Most Profound Technologies of Our Lifetime’ - Yahoo Finance
AAPL FRAUD REMINDER: Apple Inc. Stock Drop Triggers - GlobeNewswire
Apple ($AAPL) Is Paying a $490M Settlement to Investors — Here’s How to Get Your Share - TradingView
Apple's iPhone September quarter builds raised higher; turning more bullish: Morgan Stanley - Seeking Alpha
Blood Oxygen Returns to Apple Watch with iOS 18.6.1 Update - Macgasm
Buffett Dumps Apple Shares - 24/7 Wall St.
Apple September quarter iPhone build estimate raised at Morgan Stanley - TipRanks
OpenAI CEO Sam Altman Reveals 'Sci-Fi' AI Companion Vision With Ex-Apple Design Chief Jony Ive To Replace Smartphones - Benzinga
How Apple Inc. stock performs during market volatility2025 Price Action Summary & Daily Technical Stock Forecast Reports - thegnnews.com
Warren Buffett Buys UnitedHealth, Sells Apple, BofA, T-Mobile - FXLeaders
Apple Releases Sixth Developer Beta for iOS 26 - Insider Monkey
Dan Ives Says Apple's AI Strategy Has Been A… - inkl
Dan Ives Says Apple's AI Strategy Has Been A 'Disaster' And No One On The Street Believes Innovation Will Come From Within - Benzinga
Apple Vs. Apple: The Courtroom Showdown Brewing Over A Theater Chain's Name - 949whom.com
Warren Buffett's Strategic Moves: Apple Inc. Sees a -1.71% Portfolio Impact - Yahoo Finance
Gladstone Capital Management Reduces Stake in Apple Inc - TipRanks
Fisher Asset Management Boosts Stake in Apple Inc - TipRanks
Bridgewater Associates Reduces Stake in Apple Inc - TipRanks
Apple Watch gets revamped blood oxygen feature - Philstar.com
Apple Watch Blood Oxygen Tracker Back in US - MSN
Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling - AOL.com
Apple Watch blood oxygen tracker returns to U.S. after legal win - The Spokesman-Review
Amid IP Fight, Apple Restores Watch's Blood Oxygen Monitor - Law360
Apple Plans To Leave Its AI Woes Behind With A Fleet Of Home Robots - Yahoo! Tech
Apple’s SWOT analysis: stock faces legal challenges amid AI push By Investing.com - Investing.com Australia
Apple’s SWOT analysis: stock faces legal challenges amid AI push - Investing.com
Apple’s Budget iPad to Get A18 Chip and AI Features in 2026 - WebProNews
Buffett Buys $1.6 Billion Stake in UnitedHealth, Sells T-Mobile - Bloomberg.com
Apple Inc Azioni (AAPL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.60%
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):